Aspirin-Exacerbated Respiratory Disease (AERD) and the Role of Type 2 inflammation

AERD, also known as Samter’s Triad, is a condition that impacts more than 1 million people in the US. People with AERD live with asthma, sinus disease and recurrent nasal polyps, and are sensitive to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDS). Many are undiagnosed. In this webinar, Dr. Rajan Merchant will review the symptoms, causes, diagnosis, management and treatment options for those living with this challenging condition.

Speaker:

Rajan Merchant, MD, FACAAI
Woodland Clinic Medical Group, Woodland, CA
Dignity Health Medical Foundation
Common Spirit Heath Research Institute
Common Spirit Health

_______________________________________________________________________________________
ALLERGY & ASTHMA NETWORK


The mission of Allergy and Asthma Network is to end the needless death and suffering due to asthma, allergies and related conditions. We do this through outreach, education, advocacy and research. More than 24 million Americans -- including 6 million children -- have asthma. More than 50+ million live with allergies. Talk with your doctor about creating a management and treatment plan. We're working every day so that we may all breathe better together.
Allergy & Asthma Network specializes in making health information accurate and understandable to all. We bring the patient voice to healthcare and promote standards of care proven to work. Prevention, prompt diagnosis and treatment:
• helps reduce emergency healthcare visits;
• keeps children in school and adults at work;
• allows participation in sports and other activities of daily life.

More from the Allergy & Asthma Network:
Latest news articles: https://allergyasthmanetwork.org/news/
Asthma articles: https://allergyasthmanetwork.org/what...
Allergy articles: https://allergyasthmanetwork.org/alle...
Anaphylaxis articles: https://allergyasthmanetwork.org/anap...
Overlap conditions: https://allergyasthmanetwork.org/heal...
_______________________________________________________________________________________